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SUMMARY
1. The metabolism of paracetamol after a single oral
dose of 20 mg/Kg uas compared in fifteen patients with
microsomal enzyme induction taking anticonvulsants or
rifampicin, sixteen alcoholics defined by their M.A.S.T.
scores and twelve healthy volunteers.
2. The plasma antipyrine half life was used to assess
induction and the means were 6.4, 13.4, 12.8 hours in the
three groups respectively
3. As well as a reduced antipyrine half life, the induced
patients showed enhanced glucuronide conjugation of paracetamol
with correspondingly reduced excretion of the sulphate
conjugate and unchanged drug.
4. The alcoholics did not have significantly different
antipyrine half lives qrindices of glucuronide conjugation
compared to the healthy volunteers.
5. There were no significant differences between the means
of the three groups in the urinary excretion of the mercapturic
acid and cysteine conjugates of paracetamol. However, four of
the alcoholics had unusually high outputs of these two conjugates.
6. Conversion of paracetamol to its potentially hepatotoxic
metabolite does not appear to be increased in patients induced
with anticonvulsants or rifampicin. Uhether this also applies




Paracetamol is a widely used and normally very safe
analgesic. However, in overdosage it can cause acute
hepatic necrosis through the formation of a highly reactive
intermediate metabolite by hepatic cytochrome P-450
dependent microsomal enzymes (Mitchell, Hollow, Potter,
Davis, Gillette & Brodie, 1973; Mitchell, Thorgeirsson,
Potter, Hollow & Keiser, 1974). In most laboratory
animal species, the hepatotoxicity of paracetamol is
increased by pretreatment with microsomal enzyme inducers
such as phenobarbitone, 3-methylcholantnrene and ethanol
and decreased by inhibitors such as piperonyl butoxidb
(Mitchell et ai., 1973; Mitchell et al., 1974; Hollow et
al., 1974; Strubelt, Obermeier & Siegers, 1978; Teschke,
Stutz & Strohmeyer, 1979; Streeter & Timbrell, 1979).
There have been recent case reports of liver damage
following the alleged therapeutic use of paracetamol in
chronic alcoholics (Licht, Seeff & Zimmerman, 1980; Gerber,
Kaufmann, Klion & Alpert, 1980; Goldfinger, Ahmed,
Pitchumoni & Ueseley, 1978; McClain, Kromhout, Peterson
& Holtzman, 1980).After overdosage the severity of liver
damage appears to be greater in chronic alcoholics and
patients who have previously been taking drugs likely to
cause induction (Uright & Prescott, 1973).
These observations suggest that microsomal enzyme
induction might increase the production of the reactive
metabolite of paracetamol and thus enhance its hepatotoxicity.
A detailed comparison of paracetamol metabolism was/
2
was therefore carried out in healthy volunteers, induced
patients taking anticonvulsants or rifampicin and otherwise
healthy males with a history of regular substantial alcohol
ingestion. Microsomal enzyme induction was assessed by
measurement of the antipyrine half-life. The urinary
excretion of mercapturic acid and cysteine conjugates
of paracetamol uas used as an index of the extent of its




Of the fifteen patients taking hepatic microsomal
enzyme inducing drugs, thirteen were epileptics on long
term therapy with anticonvulsants given singly or in
combination - twelve were taking diphenylhydantoin (mean
daily dose 315 mg), two phenobarbitone, two carbamazepine
and one primidone. Another two patients were taking
rifampicin (600 mg) daily with isoniazid for tuberculosis.
All hut three of the induced patients were male and their
mean age and body weight were 41 years (range 22 - 72)
and 71 kg (range 53 - 99) respectively.
The plasma bilirubin, alanine aminotransferase,
albumin and creatinine were normal in all the patients
but four had mild elevation of the alkaline phosphatase.
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Alcoholic patients
Sixteen males were recruited by advertisement and
by personal contact. All gave a history of regular daily
consumption of at least half a bottle of spirits or six
pints of beer. None uas taking any other drugs regularly.
Their mean age and body weight were 40 years (range 25 - 54)
and 74 kg (range 59 - 95) respectively. A drug, alcohol,
and medical history uas taken and as an independent index
of alcohol consumption a Michigan Alcoholism Screening
Test (M.A.S.T.) questionaire uas completed (Favazza and Pires,
1974). In all sixteen subjects this revealed at least
clear evidence of alcohol related problems. Four scoired
into the substantial and one into the severe evidence
groups. Six subjects had raised plasma gamma glutamyl
transferase enzyme concentrations but only in two uere
they above 100 u/l (116 & 112 u/l).
Healthy volunteers
None of the twelve healthy volunteers took drugs
or excessive amounts of alcohol regularly. Eleven were
male and their mean age and body weight were 31 years
(range 21 - 45) and 67 kg (range 55 - 82) respectively.
EXPERIMENTAL DETAILS
Drug administration and sampling regimes
The induced patients and alcoholic patients were
admitted to hospital for the two day study.
On the first day, after an overnight fast,20 mg/kg
4
20 mg/kg of paracetamol dissolved in 400 ml of Coca Cola
was ingested over too minutes. 10 ml venous blood samples
were taken over the next eight hours at •§-, 1, 1-|, 2, 3,
4, 6, and 8 hours and all urine collected for the next
twenty four hours with the following collection periods -
0 - 4, 4 - 8, 8 - 12 and 12 - 24 hours.
On the second day, after an overnight fast, 18 rng/kg
of antipyrine dissolved in 400 ml of orange juice uas
ingested over two minutes. l/enous blood samples (10 ml)
were taken over the next twenty four hours at 0, 4, 8,
12 and 24 hours but no urine uas collected.
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The Coca Cola and orange juice were used to disguise
the taste of the drugs. All the subjects were ambulant.
Fluids and tobacco were withheld for two hours and food
for four hours after dosing.
The induced patients continued to receive their
medications during the study. To avoid problems with alcohol
withdrawal, the alcoholic patients were given 100 ml whisky
at approximately 5 pm and 10 pm on both days.
Drug analysis
Plasma and urine were stored frozen. Paracetamol
and its metabolites in plasma and urine and antipyrine
in plasma were estimated by high performance liquid
chromatography (Adriaenssens & Prescott, 1978; Prescott,
King, Broun, Balali & Adriaenssens, 1979). None of\ the






The area under the plasma concentration time
curves (AUC) uas calculated by the trapezoidal rule, the
plasma half-life from the regression of the linear
terminal elimination phase and the renal clearances by
dividing the amount of drug or metabolites excreted in
the urine by the corresponding AUC. The apparent volume
of distribution of antipyrine uas obtained by dividing
the administered dose by the extrapolated plasma concent¬
ration at zero time.
The plasma clearance of antipyrine uas estimated
by multiplying the volume of distribution by 1n2 and
dividing by the half-life. Paracetamol clearances uere
i
not calculated because its significant and variable first-
pass metabolism uould invalidate comparisons betueen the.
groups (Perucca & Richens, 1979).
Student's t test uas used for statistical comparisons
■f"
of mean data. All results are given as means - s.d. and




Induction of microsomal enzymes in the patients on
anticonvulsants or rifampicin uas confirmed by their
mean antipyrine plasma half life of 6.4 + 2.1 h compared
to that of 12.8 + 3.9 h in the healthy volunteers. (P<0.001).
Houever there uas no significant difference betueen the
half life of the latter group and that of the alcoholic




































*Significantlydifferentfromno alv lu teers(P=<0.001)
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alcoholic patients. (13.4 + 5.0 h).
The mean apparent volumes of distribution in the
healthy volunteers, induced patients and alcoholic patients
were very similar and uere 0.66, 0.65 and 0.69 1/kg
respectively.
Paracetamol and Metabolites in Plasma
The mean plasma concentrations of paracetamol and
its sulphate and glucuronide conjugates in the three
groups are shown in the Figure.
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In the induced patients paracetamol metabolism was ■
enhanced compared to the control volunteers. The former
had lower mean plasma paracetamol concentrations at all
time points, a significantly, smaller AUC 0 - 8 h and the
plasma half .life was significantly shorter (Table 1).
These differences uere due to increased glucuronide
conjugation of paracetamol in the induced patients since
the two groups had similar AUC g g ^1s for the sulphate
conjugate but the initial glucuronide concentrations and-
AUC
g g g was higher in the induced patients. The ratio
of the AUC
g g g's of paracetamol glucuronide to the
parent drug in the induced patients was more than double
that in the healthy volunteers (Table 1).
There were no significant differences between the
alcoholic patients and the healthy volunteers in any of
the plasma indices of paracetamol metabolism (Table 1)
TABLE2.Urinaryexcretionofpara etamolditsglucu onide,sulph te,merca turica idncyste conjugates ParacetamolPercentageexcretedin24 GlucuronideSulphatehas:- Hercapturicacid
Cysteine
































and thus no evidence of significant enhancement of the
latter.
Urinary Excretion of Paracetamol and Metabolites
In the healthy volunteers about 5% of the total amount
recovered in 24 hours uas excreted unchanged uith 57%
as glucuronide, 30% as sulphate, 4.5% as mercapturic acid
and 3.7% as cysteine conjugates.
In the induced patients, significantly less
paracetamol uas recovered unchanged and as sulphate uhile
significantly more uas excreted as glucuronide. The
excretion of the mecapturic acid and cysteine conjugates
uas no greater in the induced patients than in the healthy
volunteers (Table 2). There uas no evidence of initial
more rapid production of mercapturic acid and cysteine
conjugates in the patients. The pattern of urinary
excretion of paracetamol from 0 - 4 h and 0 - 24 h uas
similar and if anything the fraction excreted as
mercapturic acid and cysteine conjugates from 0 - 4 h uas
less in the patients (3.6 & 2.5%) than in the healthy volunteers
(3.8 & 2.8%).
The urinary excretion pattern in the alcoholic
patients uas not so clear cut. Uith regard to the mean
percentages of paracetamol and its metabolites excreted
over 24 hours, there uere no significant differences
betueen the alcoholic patients and the healthy volunteers.
(Table 2). In fact the percentages of the major conjugates
TABLE3.
Renalclearances(□-Bh)ofpar cetamoditsqlucu o ida sulphateconjugates RenalClearance(ml/ in) ParacetamolGlucuronideSulphat
Healthyvolunteers (n=12) Alcoholpatients (n=16) Inducedpatients (n=15)
11.9+4.931 2266 9 9.0+4 9146332287 9.0+5 5116303846
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conjugates, glucuronide and sulphate,uere virtually
identical.
Houever, the mean percentages of mercapturic acid
and cysteine conjugates uere higher in the alcoholic
patients. This uas not a reflection of an increased
output of these metabolites in the 0 -? 4 h period as
during it the proportions of all the various conjugates
uere closer to those found uith the healthy volunteers.
The higher 0 - 24 h mean percentages uere due to
surprisingly high proportions of urinary mercapturic acid
(8, 10, 10 & 14%) and cysteine (6, 7, 9,& 12%) conjugates
in four alcoholic patients. There uere no differences
betueen the M.A.S.T. scores or plasma gamma glutamyl
transferase concentrations in these four and the remainder
of the alcoholic patients.
The mean 24 hour urine volume of the alcoholic
patients (2151 ml) uas slightly higher than those of the
induced patients and healthy volunteers (1783 and 1798 ml
respectively) due to an excessive fluid intake in one
individual.
There uere no significant differences betueen the
three groups in the renal clearances of paracetamol and
its glucuronide and sulphate conjugates,(Table 3).
Individual differences in metabolism of either of the
drugs did not appear to be related to smoking habits.
DISCUSSION
Induction of drug metabolising enzymes uas confirmed
in the patients taking anticonvulsants or rifampicin by
the greatly shortened antipyrine half life and increased
clearance uithout any change in the apparant volume of
distribution. These patients had enhanced glucuronide
conjugati'orv.of paracetamol compared to the healthy volunteers.
They had a shorter plasma paracetamol half life and increased
plasma glucuronide conjugate concentrations uith an
increased ratio of the AUCof'the glucuronide to that of
paracetamol. The increased glucuronide conjugation uas
reflected in corresponding differences in the proportions
of paracetamol and its metabolites excreted uith the induced
patients excreting more glucuronide and less paracetamol or
its sulphate conjugate than the healthy volunteers.
Sulphotransferase does not appear to be induced in a similar
fashion to glucuronyl transferase and sulphate conjugation
uas not increased in the induced patients.
There uas no comparable evidence of drug metabolising
enzyme induction in the alcoholic patients. Their antipyrine
half lives and clearances uere similar to those of the
healthy volunteers and betueen the tuo groups there uere no
significant differences in paracetamol elimination and
glucuronide or sulphate conjugation.
All our sixteen subjects claimed to have been drinking
substantial amounts of alcoholic beverages for at least a feu
years and their classification as alcoholics uas supported
supported by their FI.A.S.T. scores. This test has been
described as identifying with almost perfect accuracy
individuals diagnosed as having alcoholism (Favazza and Pires,
1974). Only a third of our patients had raised plasma gamma
glutamyl transferase concentrations. However, there is
increasing evidence that this is not a reliable index of high
alcohol intake alone.
Although alcohol is often listed as an inducer of
hepatic microsomal enzymes, many of the studies on which
this claim is based have considerable shortcomings (Sellers
and Holloway, 1978). No correlation between antipyrine
metabolism and alcohol consumption was found in 291 subjects
from the Baltimore Longitudinal Study of Aging (Vestal et al,
1975). Although Vesell et al (1971) found that in six subjects
modest alcohol consumption for three weeks was associated with
a 4 - 37% reduction in antipyrine half life, alcohol does not
appear to have an inducing action comparable to that of
diphenylhydantoin or rifampicin.
There is evidence that acute alcohol administration
inhibits hepatic drug metabolism (Rubin and Lieber, 1971;
Sellers and Holloway, 1978). However, the small amounts of
study
alcohol given in the present/,atleast eight hours after drug
administration, were unlikely to have had significant effects.
The same argument applies to the continuation of therapy in
the induced patients and aawith the alcohol,more closely
mimics the situation found in clinical practice.
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Previous studies in man on the effects of microsomal
enzyme induction on paracetamol metabolism have given
conflicting results. Perucca and Richens (1979) demonstrated
reduced oral bioavailability of paracetamol uhich they
attributed to increased first-pass metabolism in six epileptics
compared with six normal subjects. The mean total body
clearance and elimination rate uere higher in the former group
but the differences uere not significant. No data uas provided
on the individual metabolites of paracetamol and the mercapturic
acid and cysteine conjugates uere not measured. Houever,
Mitchell et al. (1974) found that pretreatment uith 3 mg/Kg
of phenobarbitone for five days had no effect on the plasma
half life of paracetamol in seven healthy volunteers a'lthough
formation of the mercapturic acid conjugate uas increased.
The mercapturic acid and cysteine conjugates reflect
the conversion of paracetarnol to the potentially hepatotoxic
metabolite. In animals the fraction of a dose converted to the
mercapturic acid conjugate is highest in species most susceptible
to the hepato toxicity of paracetamol and louest in those most
resistant. Similarly, inducing agents uhich potentiate
paracetamol liver toxicity also increase mercapturic acid
conjugate production uhile its formation is decreased by
protective treatments. (Dollou et al., 1974; Sato, flatsuda and
Lieber, 1979) .
In the present study no increase in the urinary excretion
of mercapturic acid and cysteine conjugates uas found in the
induced patients. Houever, as these patients shoued enhanced
conversion of paracetamol to the glucuronide conjugate,
a corresponding fall in the output of the mercapturic acid
and cysteine conjugates might have been expected similar to
that occuring uith the parent drug and its sulphate conjugate.
Thus some induction of the oxidative metabolism of paracetamol
cannot be excluded but does not appear to be of clinical
significance at the dose used in this study.
Although there uas no significant overall increase in
mercapturic acid and cysteine conjugate production in the
alcoholic patients, a number of individuals had relatively
high outputs of these conjugates. There uas no other evidence
of microsomal enzyme induction and this may reflect selective
activation of one of the multiple forms of cytochrome 1P-450
by alcohol. The present study leaves unresolved the question
of whether therapeutic doses of paracetamol are potentially
hepatotoxic in alcoholic patients and further work is planned.
Paracetamol metabolism is dose dependent (Prescott, 1980)
Thus,- although there is no evidence that anticonvulsant or
antituberculous therapy may increase the risk of hepatotoxicity
uith therapeutic doses of paracetamol, this is not necessarily
the case after overdosage.
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